CANNAGE CAPITAL
CANNAGE CAPITAL is a Pre-seed, Seed and Series A fund in the US writing $250K–$3.5M checks into AI, Fintech, Healthcare, biotechnology, consumer-technology, semiconductors, software-infrastructure and applications.
- Stages
- Pre-seed, Seed, Series A
- Sectors
- AI, Fintech, Healthcare, biotechnology, consumer-technology, semiconductors, software-infrastructure, applications
- Check size
- $250K–$3.5M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2024
- Assets under management
- $100M
- Website
- cannagecap.com
Thesis
Cannage Capital is a venture capital firm founded in 2024 and based in Las Vegas, Nevada. The firm focuses on early-stage companies, investing across the AI stack, which includes semiconductors, software infrastructure, and applications across various industries. Their investment strategy spans multiple sectors, including artificial intelligence, biotechnology, healthcare, fintech, and consumer technology. They target companies at the pre-seed, seed, seed-plus, and Series A stages. Cannage Capital primarily invests in companies based in the United States. Cannage Capital manages one active investment vehicle, Cannage Capital I, which opened to limited partners in May 2024.
Common questions
Does CANNAGE CAPITAL invest at the Pre-seed stage?
Yes. CANNAGE CAPITAL lists Pre-seed, Seed and Series A among the stages it invests in.
What check size does CANNAGE CAPITAL write?
CANNAGE CAPITAL writes $250K–$3.5M checks.
Where does CANNAGE CAPITAL invest?
CANNAGE CAPITAL invests in the US.